0001849682-22-000003.txt : 20220602
0001849682-22-000003.hdr.sgml : 20220602
20220602172935
ACCESSION NUMBER: 0001849682-22-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220531
FILED AS OF DATE: 20220602
DATE AS OF CHANGE: 20220602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dhingra Ankur
CENTRAL INDEX KEY: 0001849682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 22992109
MAIL ADDRESS:
STREET 1: C/O CAREDX, INC.
STREET 2: 1 TOWER PLACE, 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wf-form4_165420535405545.xml
FORM 4
X0306
4
2022-05-31
0
0001599298
Summit Therapeutics Inc.
SMMT
0001849682
Dhingra Ankur
C/O SUMMIT THERAPEUTICS INC.
2882 SAND HILL ROAD, SUITE 106
MENLO PARK
CA
94025
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
1.33
2022-05-31
4
A
0
600000
A
2032-05-31
Common Stock
600000.0
600000
D
The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date).
Not applicable.
/s/ Ankur Dhingra
2022-06-02